glp-1 peptide dosage Research shows drugs are effective but complex How Much Does Semaglutide GLP-1

GLP-1 Market Share, By Indication, 2025 (%) The obesity and weight management segment held a 28% share of the market in 2025 and is expected to grow at the fastest CAGR of 18.6% during the projection period

Endocrine Drug-induced secondary adrenocortical insufficiency may be minimized by gradual reduction of dosage

Lifestyle Behaviors Simple daily habits significantly influence the rate of weight loss

Plaintiffs argue that companies like Novo Nordisk and Eli Lilly ignored clinical trial data, post-marketing surveillance, and adverse event reports that pointed to dangers such as stomach paralysis, intestinal obstruction, and permanent vision damage